Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

104.79 -2.96 (-2.75%)
Streaming Delayed Price Updated: 11:50 AM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript ↗
GKOS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Glaukos Corporation Announces Second Quarter 2021 Financial Results
From Glaukos Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021 ↗
Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
From Glaukos Corporation
Via Business Wire
News headline image
62 Biggest Movers From Yesterday ↗
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Why Glaukos Shares Dipped Today ↗
Glaukos (NYSE:GKOS) shares are trading lower after Wells Far... 
Via Benzinga
News headline image
Glaukos plunges after CMS suggests slashing iStent reimbursement ↗
William Blair downgraded Glaukos following the 
Via Talk Markets
News headline image
Why Glaukos Stock Sank Today ↗
An analyst downgraded the healthcare stock. 
Via The Motley Fool
News headline image
Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts ↗
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
News headline image
Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5
From Glaukos Corporation
Via Business Wire
News headline image
55 Biggest Movers From Yesterday ↗
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge ↗
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX 
Via Benzinga
News headline image
Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge ↗
Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
34 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution... 
Via Benzinga
News headline image
Why Glaukos Stock Is Tanking Today ↗
Proposed rates from CMS for fiscal 2022 weren't what investors expected. 
Via The Motley Fool
News headline image
Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations ↗
Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S.... 
Via Benzinga
Topics Earnings Stocks
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 ↗
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop ↗
Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure... 
Via Benzinga
News headline image
Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level ↗
Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist? 
Via Investor's Business Daily
News headline image
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
From Glaukos
Via Business Wire
News headline image
Glaukos Announces Participation in the William Blair 41st Annual Growth Stock Conference
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript ↗
GKOS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Glaukos Corporation Announces First Quarter 2021 Financial Results
From Glaukos Corporation
Via Business Wire
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.